According to the New York Times, Johnson & Johnson has pledged to remove a number of potentially harmful chemicals, including formaldehyde, from its line of consumer products by the end of 2015.
Although the company had already pledged to remove certain chemicals from its baby products by 2013, the new announcement extends the program to its adult products. Johnson & Johnson is the first major consumer products company to make such ...
continue reading...
Johnson & Johnson has agreed to pay about $600,000 to resolve three cases in the first settlements of lawsuits related to the company’s all-metal hip implants, Bloomberg reports.
The report, which cites unnamed sources, says officials with Johnson & Johnson’s DePuy unit recently agreed to settle Nevada residents’ suits over the devices, which were recalled in 2010.
The hip implants in question ...
continue reading...
The U.S. Food and Drug administration has ordered St. Jude Medical to do additional studies on patients implanted with medical device components that are blamed in as many as 20 deaths.
According to the New York Times, the FDA has also recommended that patients who received the Riata defibrillator lead — a wire that connects a defibrillator to a patient’s heart — get X-rays or other imaging to check for problems.
The ...
continue reading...
A story from the U.K.’s “Manchester Evening News” tells the story of a 57-year-old mother of two who spent months unable to work or leave her house because of a DePuy all-metal artificial hip implant.
Sally Gration, 57, underwent hip replacement surgery in February 2006 to treat hip dysplasia, or a malformed hip joint.
Initially, the surgery appeared to be successful. But she began suffering excruciating pain in 2010 – the year ...
continue reading...According to a story in the New York Times, a renewed U.S. Justice Department emphasis on prosecuting corporate fraud is expected to bring in as much as $8 billion this year from pharmaceutical companies, military contractors, banks and other corporations charged with defrauding the government, which amounts to a record sum.
Still, the lack of charges against executives at those companies is resurrecting questions about accountability, and just how much of ...
continue reading...A prominent Wall Street analyst is suggesting that the best way for Johnson & Johnson to cope with its many problems would be to break into smaller companies, according to an article in the Asbury Park Press.
Jami Rubin of Goldman Sachs suggests that splitting Johnson & Johnson’s three divisions into separate companies would free up money to invest, help the company grow faster and provide a bigger return to shareholders.
The ...
continue reading...
